Innoviva Inc reports results for the quarter ended in September 30 - Earnings Summary

Innoviva

07/11/2024 04:10

* Innoviva Inc  INVA.OQ  reported quarterly adjusted
earnings of 2
cents​​ per share for the quarter ended September 30, lower than
the same quarter last year, when the company reported EPS of 98
cents.  The mean expectation of two analysts for the quarter was
for earnings of 27 cents per share. Wall Street expected
results to range from 22 cents to 31 cents per share.
    * Revenue rose 33.1% to $89.51 million from a year ago;
analysts
expected $76.91 million. 
    * Innoviva Inc shares had risen by 0.6% this quarter and
gained 21.1% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is  "hold."

Wall Street's median 12-month price target for Innoviva Inc is
$18.00 
This summary was machine generated from LSEG data November 7 at
04:09 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      0.27           0.02           Missed
 Jun. 30 2024      0.24           -0.55          Missed
 Mar. 31 2024      0.17           0.46           Beat
 Dec. 31 2023      0.23           0.76           Beat